In this episode of Analyzing Healthcare by SCALE Community proudly supported by SCALE Healthcare x JPMorgan, we dive deep with John McDonough, professor at the Harvard T.H. Chan School of Public Health, to explore the growing public health crisis driven by federal research funding cuts. McDonough dissects the Harvard funding crisis, the erosion of grant-supported research institutions, and the challenges facing academic medical research under the Trump administration and beyond. We examine how shifts in healthcare policy research, NIH funding threats, and the impact of political funding decisions are reshaping public health, particularly in health disparities research, environmental health studies, and population health innovation. The conversation also contrasts the U.S. and European healthcare systems, highlights the limitations of value-based care, and emphasizes the importance of state-level healthcare policy experimentation in advancing more equitable, sustainable solutions.

Title: John McDonough on Population Health, Research Disruption & the Harvard Funding Crisis | Analyzing Healthcare | SCALE Community

Key Timestamps:

• (00:00) Introduction to Harvard T.H. Chan School of Public Health
• (03:00) The Role of Research in Public Health
• (06:10) Nutrition and Public Health Research
• (09:05) Population Health vs. Public Policy
• (11:56) Healthcare Spending and Health Outcomes
• (14:51) The Obesity Crisis in America
• (18:01) Environmental Health Determinants
• (22:54) EU vs. US Healthcare System: A Comparative View
• (27:06) Structural Challenges in the U.S. Healthcare System
• (31:58) Value-Based Care: Insights & Limitations
• (40:41) Why State-Level Policy Variations Matter

Key Takeaways:

• The academic funding crisis threatens long-term innovation in public health education and healthcare research.
• Nutrition research and environmental health studies remain critically underfunded.
• The U.S. prioritizes reactive care over preventive population health initiatives.
• Obesity and environmental factors drive poor health outcomes.
• State-level experimentation could be a catalyst for nationwide policy change.
• Despite challenges, opportunities exist to refocus research investment on health equity, health system innovation, and population-level outcomes.

⁠linkedin.com/in/john-mcdonough-2bb49825⁠

⁠linkedin.com/in/roy-bejarano-a5669ba8⁠

⁠www.scale-community.com ⁠

About the Guest:

John McDonough is a renowned health policy expert and Harvard professor whose work has shaped U.S. healthcare reform, including key roles in the Affordable Care Act. With decades of experience in government, academia, and advocacy, he brings unmatched insight into health systems, policy analysis, and public health—making him a leading voice in the national healthcare conversation.

Keywords

Harvard TH Chan, Public Health, Nutrition, Healthcare Policy, Population Health, Obesity, Environmental Health, Research Funding, Health Outcomes, Healthcare Spending, Healthcare Systems, Europe, US Healthcare, Value-Based Care, State Policy, Healthcare Outcomes, Investment, Patient Care, Medical Care, Population Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman